PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC has commenced an investigation of Inogen, Inc. (“Inogen” or the “Company”) (NASDAQ: INGN) on behalf of the Company’s stockholders.
Stockholders who purchased shares of Inogen’s common stock before November 8, 2017 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (888) 715 – 1740, or via email at firstname.lastname@example.org, to discuss this investigation and their legal rights and options. Additional information about this investigation may also be requested at http://kaskelalaw.com/case/inogen/.
In March 2019, a shareholder securities fraud complaint was filed against the Company in federal court on behalf of certain purchasers of Inogen’s common stock. Among other things, the securities fraud complaint alleges that Inogen violated the federal securities laws by making a series of materially false and misleading statements to investors about the Company’s business, operations and prospects.
Kaskela Law LLC is investigating whether Inogen’s executive officers and/or directors breached their fiduciary duties to the Company and its stockholders in connection with the above alleged misconduct.
Kaskela Law LLC prosecutes shareholder actions in state and federal courts throughout the country on behalf of investors. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.